Zorifertinib
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Zorifertinib Plus Intra-Ommaya CSF Chemotherapy for Leptomeningeal Progression in NSCLC After Third-Generation EGFR-TKI (NCT07551414) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2026-05-30 |
Track Zorifertinib automatically
Every clearance here is in the API, with alerts when new ones post.